Key Takeaways
- Cornell’s Center for Technology Licensing (CTL) honored 82 first‑time inventors and 306 inventors whose technologies were licensed or optioned in FY 2024‑25 at the “Bearers of Innovation: A One Cornell Celebration.”
- Over 1,000 Cornell technologies are now licensed to more than 500 industry partners worldwide, and the university launched 20 new technology ventures in FY 2024‑25—a record.
- In the past five years, Cornell‑affiliated startups have raised > $2.4 billion in funding.
- Keynote speakers Robbert Van Renesse and Hakim Weatherspoon described the decade‑long path from invention disclosure to the Qualcomm acquisition of their cloud‑efficiency startup, Exostellar, stressing agility, market‑driven pivots, and the role of programs like NSF I‑Corps.
- Jason Spector, M.D., shared how a clinical frustration led to DermiSphere, an FDA‑cleared wound‑healing device, and advised researchers to stay discreet early, build networks, and engage CTL first.
- The event highlighted Cornell’s broader innovation ecosystem—incubators, mentors, industry partners, and CTL staff—as a decisive factor in moving research from lab to market.
- Cornell ranked No. 20 among U.S. universities for utility patents granted in 2025 (103 patents), underscoring its prolific inventive output.
Event Overview
On May 20, Cornell’s Center for Technology Licensing hosted “Bearers of Innovation: A One Cornell Celebration” in Ithaca, with a simultaneous livestream to Weill Cornell Medicine in New York City. The gathering recognized inventors who submitted their first invention disclosure to CTL in fiscal years 2024 or 2025, as well as those whose technologies were licensed or optioned during the same period. Executive Director Alice Li opened the event by emphasizing that moving work beyond the lab is now more critical than ever, noting that Cornell’s portfolio includes over 1,000 licensed technologies serving more than 500 industry partners worldwide.
Scale of Technology Transfer
Li highlighted the magnitude of Cornell’s commercialization impact: more than 1,000 technologies licensed, 20 new technology ventures launched in FY 2024‑25 (an institutional record), and a cumulative >$2.4 billion raised by Cornell‑affiliated startups over the past five years. These figures illustrate how the university’s research translates into economic activity, job creation, and solutions that reach patients, manufacturers, and consumers across the globe.
Inventor Recognition
The ceremony honored 82 lead inventors for their first disclosure and 306 inventors whose innovations were licensed or optioned. Senior Managing Director Lisa Placanica praised the honorees for leading not only with scientific rigor but also with a commitment to purposeful discovery that addresses real‑world needs. Their work spans multiple disciplines, reflecting Cornell’s interdisciplinary strength.
Ithaca‑Based Inventors
Inventors from the Ithaca campus attended the event in person, representing colleges such as the Duffield College of Engineering, College of Veterinary Medicine, College of Agriculture and Life Sciences, College of Human Ecology, Ann S. Bowers College of Computing and Information Science, and others. Their presence underscored the geographic and academic diversity of Cornell’s inventive community.
New York City‑Based Inventors
Simultaneously, inventors based at Weill Cornell Medicine participated via livestream. The New York City cohort included clinician‑innovators whose work directly impacts patient care, demonstrating how Cornell’s medical campus contributes to the university’s overall innovation pipeline.
Keynote Speakers: Van Renesse & Weatherspoon
Robbert Van Renesse (Professor of Computer Science) and Hakim Weatherspoon (Professor of Computer Science and Associate Dean at Cornell Bowers) delivered the keynote, streamed live from Ithaca to New York City. They recounted the ten‑year journey that led to Exostellar, a startup founded on technology developed in their labs to improve cloud‑computing efficiency. The company was acquired by Qualcomm earlier in the year, marking a significant milestone for Cornell‑born ventures.
Exostellar’s Journey and Market Discovery
The speakers emphasized that Exostellar’s success was not linear. Through participation in the NSF I‑Corps program—which involved more than 90 customer interviews—Van Renesse, Weatherspoon, and co‑founder Zhiming Shen refined their understanding of market demand. They discovered that companies were eager to reduce spending on underutilized cloud resources, prompting several pivots before arriving at a viable product. Van Renesse noted, “We went through many pivots until we found something that people were actually interested in,” while Weatherspoon added, “You don’t have to wait for the perfect solution; you have to be agile.”
Lessons from I‑Corps and Commercialization Mindset
Weatherspoon articulated that commercialization is an extension of research, not a separate activity. He stressed the necessity of talking to the market to learn what customers will actually pay for, what they need, and what gaps exist. The acquisition by Qualcomm—dubbed “Chapter 8” of the story—was only possible after earlier stages: invention disclosure, prototype development, I‑Corps training, SBIR grants, local investor support, mentorship, and business incubation. “The acquisition is Chapter 8. Chapters 1‑7 are what got us there,” he said, highlighting the cumulative nature of the entrepreneurial process.
Fireside Chat: Jason Spector, M.D.
In New York City, Jason Spector, Chief of Plastic and Reconstructive Surgery at Weill Cornell Medicine and co‑founder of Fesarius Therapeutics, joined Lisa Placanica for a fireside chat. He described how frustration with slow wound‑healing devices in the operating room led to DermiSphere, a collagen‑based product that received FDA 510(k) clearance in 2025. Spector explained that accelerating vascularization saves patients time, reduces surgeries, and improves recovery outcomes. When asked what a researcher should do first in commercialization, he offered three concrete steps: stay discreet with the idea early, build a strong network, and reach out to CTL as an initial point of contact.
Cornell’s Innovation Ecosystem
The event also celebrated the broader ecosystem that enables inventor success. Krystyn Van Vliet, Vice President for Innovation and External Engagement Strategy at Cornell Research and Innovation, pointed to the range of technologies Cornell has brought to market—from plant varieties developed decades ago to cutting‑edge computer chips today. She noted that the ecosystem—comprising business incubators, accelerators, mentors, department chairs, industry partners, and the CTL team—is intentionally built for Cornell and is not universally present at other universities.
Patent Rankings and Impact
According to the National Academy of Inventors, Cornell ranked No. 20 among the top 100 U.S. universities for utility patents granted in calendar year 2025, with 103 patents. This placement reflects the university’s prolific inventive activity and underscores that each patent represents a technology progressing through the commercialization pathway—whether it becomes a licensed product, a startup, or a clinical advancement that reaches patients or markets.
Closing Reflections
The Bearers of Innovation gathering illustrated how Cornell’s commitment to moving discovery from laboratory to marketplace is supported by a robust infrastructure, dedicated leadership, and inventive faculty across disciplines. By celebrating both individual achievements and the collective ecosystem, the event reinforced the message that purposeful research, when paired with strategic commercialization steps, can yield tangible societal and economic benefits.